chr9-137048820-A-G

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_203468.3(ENTPD2):​c.1325T>C​(p.Leu442Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000198 in 1,415,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.000020 ( 0 hom. )

Consequence

ENTPD2
NM_203468.3 missense

Scores

9
7
3

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.14

Publications

0 publications found
Variant links:
Genes affected
ENTPD2 (HGNC:3364): (ectonucleoside triphosphate diphosphohydrolase 2) The protein encoded by this gene is the type 2 enzyme of the ecto-nucleoside triphosphate diphosphohydrolase family (E-NTPDase). E-NTPDases are a family of ecto-nucleosidases that hydrolyze 5'-triphosphates. This ecto-ATPase is an integral membrane protein. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.91

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ENTPD2NM_203468.3 linkc.1325T>C p.Leu442Pro missense_variant Exon 9 of 9 ENST00000355097.7 NP_982293.1 Q9Y5L3-1
ENTPD2NM_001246.4 linkc.1256T>C p.Leu419Pro missense_variant Exon 9 of 9 NP_001237.1 Q9Y5L3-2
ENTPD2XM_011519212.3 linkc.1016T>C p.Leu339Pro missense_variant Exon 8 of 8 XP_011517514.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENTPD2ENST00000355097.7 linkc.1325T>C p.Leu442Pro missense_variant Exon 9 of 9 1 NM_203468.3 ENSP00000347213.2 Q9Y5L3-1
ENTPD2ENST00000312665.7 linkc.1256T>C p.Leu419Pro missense_variant Exon 9 of 9 1 ENSP00000312494.5 Q9Y5L3-2
ENTPD2ENST00000460614.1 linkn.714T>C non_coding_transcript_exon_variant Exon 2 of 2 1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.0000299
AC:
6
AN:
200470
AF XY:
0.0000184
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000332
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000235
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000210
GnomAD4 exome
AF:
0.0000198
AC:
28
AN:
1415348
Hom.:
0
Cov.:
39
AF XY:
0.0000114
AC XY:
8
AN XY:
698990
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32500
American (AMR)
AF:
0.0000489
AC:
2
AN:
40858
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23038
East Asian (EAS)
AF:
0.000154
AC:
6
AN:
38870
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79150
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49140
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5552
European-Non Finnish (NFE)
AF:
9.19e-7
AC:
1
AN:
1087958
Other (OTH)
AF:
0.000326
AC:
19
AN:
58282
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.0000435
Hom.:
0
Bravo
AF:
0.0000340
ExAC
AF:
0.0000250
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 29, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1325T>C (p.L442P) alteration is located in exon 9 (coding exon 9) of the ENTPD2 gene. This alteration results from a T to C substitution at nucleotide position 1325, causing the leucine (L) at amino acid position 442 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.96
BayesDel_addAF
Uncertain
0.087
D
BayesDel_noAF
Pathogenic
0.18
CADD
Pathogenic
31
DANN
Uncertain
1.0
DEOGEN2
Benign
0.25
T;.
Eigen
Uncertain
0.66
Eigen_PC
Uncertain
0.50
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.87
D;D
M_CAP
Pathogenic
0.33
D
MetaRNN
Pathogenic
0.91
D;D
MetaSVM
Benign
-0.59
T
MutationAssessor
Pathogenic
4.0
H;.
PhyloP100
7.1
PrimateAI
Pathogenic
0.88
D
PROVEAN
Pathogenic
-6.6
D;D
REVEL
Uncertain
0.52
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
D;D
Vest4
0.83
MutPred
0.81
Loss of stability (P = 0.0345);.;
MVP
0.85
MPC
0.42
ClinPred
1.0
D
GERP RS
2.8
Varity_R
0.99
gMVP
0.98
Mutation Taster
=34/66
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs778985603; hg19: chr9-139943272; API